Showing results (3111-3120 of 9,875) with videos related to

Sort By:
Pageof 988
Biological Psychiatry|March 8, 2000
Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [(123)I]beta-CITM Laruelle, A Abi-Dargham, C van Dyck, et al.
Biological Psychiatry|March 8, 2000
Eye-tracking dysfunction (ETD) in families with sporadic and familial schizophreniaR Lencer, C P Malchow, K Trillenberg-Krecker, et al.
Biological Psychiatry|March 8, 2000
P300 reduction and prolongation with illness duration in schizophreniaD H Mathalon, J M Ford, M Rosenbloom, et al.
Biological Psychiatry|March 8, 2000
IV glycine and oral D-cycloserine effects on plasma and CSF amino acids in healthy humansD C D'Souza, R Gil, K Cassello, et al.
Biological Psychiatry|March 8, 2000
Olanzapine increases slow-wave sleep: evidence for blockade of central 5-HT(2C) receptors in vivoA L Sharpley, C M Vassallo, P J Cowen
Biological Psychiatry|August 6, 1999
Cognition and control in schizophrenia: a computational model of dopamine and prefrontal functionT S Braver, D M Barch, J D Cohen
Biological Psychiatry|August 6, 1999
The course of depressive symptoms in predicting relapse in schizophrenia: a double-blind, randomized comparison of olanzapine and risperidoneG D Tollefson, S W Andersen, P V Tran
Biological Psychiatry|September 24, 1999
Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspectiveJ A Lieberman
Biological Psychiatry|September 24, 1999
Antibodies against a neuron-like (HTB-10 neuroblastoma) cell in children with Tourette syndromeH S Singer, J D Giuliano, B H Hansen, et al.
Biological Psychiatry|September 24, 1999
Citalopram and desmethylcitalopram in vitro: human cytochromes mediating transformation, and cytochrome inhibitory effectsL L von Moltke, D J Greenblatt, J M Grassi, et al.
Pageof 988